TLR7 and psoriasis: Topical application of IMQ, a toll-like receptor 7/8 agonist, on mouse skin causes immune cell accumulation, releasing cytokine and ROS, which damages dermal and epidermal tissues, leading to psoriasis-like skin changes (Baek et al., 2012; El Malki et al., 2013).